Literature DB >> 8536612

Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.

J Yu1, L Y Xie, A B Abou-Samra.   

Abstract

The hypothalamic-pituitary-adrenal axis is an essential physiological system in many species. CRF, the major neuropeptide regulating ACTH secretion, is highly conserved in its primary sequence. Evolutionary conservation of the CRF sequence suggests that the CRF receptor (CRF-R) complementary DNA and examined its properties. The avian CRF-R complementary DNA encodes a 420-amino acid protein that is 87-88% identical to those of human, rat, and mouse. Most sequence divergence occurs in the putative signal peptide and the extracellular amino-terminus of the receptor. Five additional amino acids are inserted in the amino-terminus of the cCRF-R. When expressed in COS-7 cells, the cCRF-R binds the CRF and urotensin I radioligands with high affinities. Urotensin I competes for binding to the chicken CRF-R, expressed in COS-7 cells, with an apparent affinity 20 times higher than that of CRF. Both urotensin I and sauvagine were more effective in stimulating cAMP accumulation in COS-7 cells transfected with the cCRF-R than CRF. The effects of CRF and urotensin I on inositol phosphate accumulation were also tested. Urotensin I was an effective as CRF in stimulating inositol phosphate accumulation in COS-7 cells transfected with the cCRF-R. These data suggest that the sequence of the CRF-R is highly conserved from avian to mammalian species and that, despite its high sequence homology to the type A mammalian CRF-R, the ligand binding properties of cCRF-R are similar to those of the type B CRF-R i.e. a higher affinity for urotensin I than for CRF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536612     DOI: 10.1210/endo.137.1.8536612

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Molecular cloning and initial characterization of African green monkey (Cercopithecus aethiops) corticotropin releasing factor receptor type 1 (CRF1) from COS-7 cells.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Alexander Pisarchik; Jacobo Wortsman
Journal:  Gene       Date:  2006-11-10       Impact factor: 3.688

2.  Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.

Authors:  A Rühmann; I Bonk; C R Lin; M G Rosenfeld; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  The locus ceruleus responds to signaling molecules obtained from the CSF by transfer through tanycytes.

Authors:  Cheng-Yuan Feng; Larisa M Wiggins; Christopher S von Bartheld
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

4.  Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.

Authors:  F M Dautzenberg; S Wille; R Lohmann; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 5.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

6.  Neuropeptide binding reflects convergent and divergent evolution in species-typical group sizes.

Authors:  James L Goodson; Andrew K Evans; Y Wang
Journal:  Horm Behav       Date:  2006-04-27       Impact factor: 3.587

7.  Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1.

Authors:  B A Hofmann; S Sydow; O Jahn; L van Werven; T Liepold; K Eckart; J Spiess
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.